Cost‐effectiveness analysis of cabozantinib as second‐line therapy in advanced hepatocellular carcinoma
Wei‐Ting Liao(Wuhan University), Qiu Li(Jiangsu University)
Cited by 50
Related Papers
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
|Signal Transduction and Targeted Therapy|2022|257
Acrylamide Induces Mitophagy and Alters Macrophage Phenotype via Reactive Oxygen Species Generation
|International Journal of Molecular Sciences|2021|37
Glucose-6-phosphate dehydrogenase neutralizes stresses by supporting reductive glutamine metabolism and AMPK activation
|Signal Transduction and Targeted Therapy|2021|29
CBAP regulates the function of Akt-associated TSC protein complexes to modulate mTORC1 signaling
|Journal of Biological Chemistry|2023|4